JPS59134718A - Tacky plaster base - Google Patents

Tacky plaster base

Info

Publication number
JPS59134718A
JPS59134718A JP58008132A JP813283A JPS59134718A JP S59134718 A JPS59134718 A JP S59134718A JP 58008132 A JP58008132 A JP 58008132A JP 813283 A JP813283 A JP 813283A JP S59134718 A JPS59134718 A JP S59134718A
Authority
JP
Japan
Prior art keywords
rubber
base
yobaihi
ryujo
tacky
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP58008132A
Other languages
Japanese (ja)
Inventor
Mareyoshi Sawaguchi
希能 澤口
Komakazu Nishii
西井 駒和
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nitto Denko Corp
Original Assignee
Nitto Electric Industrial Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nitto Electric Industrial Co Ltd filed Critical Nitto Electric Industrial Co Ltd
Priority to JP58008132A priority Critical patent/JPS59134718A/en
Publication of JPS59134718A publication Critical patent/JPS59134718A/en
Pending legal-status Critical Current

Links

Abstract

PURPOSE:The titled plaster base that is made by adding YOBAIHI and RYUJO to a rubber tacky substance, thus keeping the active ingredients stable without their decomposition. CONSTITUTION:RYUJO [a kind of herb drug: made from seeds of Salix babylonica, containing salicin (a saligenin glucoside) and populin (benzylsalicin)] and YOBAIHI (bark of Myrica rubra SIEBOLD et ZUCCARINI) are added to a rubber tacky substance such as natural rubber, synthetic rubber or their mixture. The amount of RYUJO is 0.1-4wt% and YOBAIHI, 0.1-5wt% based on the tacky base. When they are used in the form of extracts, the amounts are 0.01- 2wt%, respectively. The resultant base is very useful, when the plaster contains compounds bearing phenolic hydroxyls such as salicylic acid derivatives and amines such as ethylenediamine antihistamics as active ingredients, which are remarkably lowered in their contents in the conventional rubber base.

Description

【発明の詳細な説明】 本発明は粘霜性貼付製剤用の!14・体及びこの骨体を
使用した粘右性貼イ」製剤に関する。史に詳しくは本発
明は、粘ネ1性貼付製剤用として使用される粘着性物質
よりなる骨休の改良及び当該改良された′―・体に史に
薬物を配合してなる粘着性貼付裂創に関する。
DETAILED DESCRIPTION OF THE INVENTION The present invention is for use in mucilaginous adhesive preparations! 14. Concerning the body and a viscous patch preparation using the bone body. More specifically, the present invention relates to an improvement in bone healing made of an adhesive substance used for a viscous adhesive patch preparation, and the invention relates to an adhesive patch made of an adhesive substance used for a viscous patch preparation, and an adhesive patch prepared by adding a drug to the body. Regarding.

従来、外皮に投与する薬物は殺菌剤、消lj剤、皮膚刺
激剤などの外皮、その下部組懺に局所的に作用させるこ
とを目的とするものであった。しかし、近年全身作用を
有する薬物を外皮より投与する試みがなされており、神
々の薬物の外皮投与が提案ないし試みられている。
Conventionally, drugs administered to the integument have been intended to locally act on the integument and its lower structure, such as bactericidal agents, disinfectants, and skin irritants. However, in recent years, attempts have been made to administer drugs with systemic effects through the dermis, and cutaneous administration of divine drugs has been proposed or attempted.

薬物の外皮投与は、たとえば粘着性物質よりなる骨休に
薬物を配合した粘右性貼付装罰の形悲にテ行われている
が、ゴム系粘着性物質よりなる骨体に薬物を配合した製
剤を長期味存した場合、薬物の分解、揮散などにより当
該製剤による治似効果が者しく低下する傾向かある。
For example, cutaneous administration of drugs is carried out in the form of a sticky patch, in which the drug is blended into a bone structure made of a sticky substance, but in some cases, the drug is blended into a bone structure made of a rubber-based adhesive substance. When a preparation is kept for a long period of time, the therapeutic effect of the preparation tends to decrease significantly due to decomposition and volatilization of the drug.

ところで、薬物の揮散、光分解はアルミニウムラミネー
ト包装等によって密刺、遮光することによってこれを防
止することかできるか、ゴム系粘着性物質よりなる骨休
に配合された薬物、とりわけフェノール往水酸基含旬化
合9人アミン系化合物などは、アルミニウムラミネート
包装によっても薬物の分解がいぜんとして進行し、2〜
3年の貯威によって使用に剛えなくなるものも少なくな
い。特に、消炎鎮涌剤としてのサリチル故メチル、サリ
チル前モノグリコール等のサリチル醒駒尋体、カブサイ
シン、ノニルバニリルアミド、トウカラシエキス等の皮
膚刺激剤、ジフェンヒドラミン等のエタノールアミン系
抗ヒスタミン、dt−α−トコフエロール等のビタミン
E等の経日による含量低下が者るしい。
By the way, is it possible to prevent the volatilization and photodecomposition of drugs by closely covering them with aluminum laminate packaging and shielding them from light? Even with aluminum laminated packaging, the decomposition of drugs such as amine compounds continues to progress, resulting in
Many items become unusable after three years of storage. In particular, anti-inflammatory agents such as salicyl late methyl and salicyl monoglycol, skin irritants such as kabsaicin, nonylvanillylamide, and pepper extract, ethanolamine antihistamines such as diphenhydramine, and dt. -The content of vitamin E, such as α-tocopherol, decreases over time.

従って、薬物を配合しても当該薬物の分解が進行しない
粘着性物質よりなる膏体ないし、粘着性貼付製剤の曲発
が望まれている。
Therefore, it is desired to develop a plaster or an adhesive patch made of an adhesive substance in which the decomposition of the drug does not proceed even if the drug is mixed therein.

かかる実情下に、本発明者らは神々研究を重ねてきたと
ころ、ゴム系粘着性物質よりなる膏体に、柳紫及び@梅
反を配合しておけは、当該旬・体に薬物を配合しても薬
物が分解することなく安定に仔在することを見出した。
Under these circumstances, the inventors of the present invention have conducted extensive research and have found that if a paste made of a rubber-based adhesive substance is mixed with Yanagiji and @Umetan, then the drug will not be added to the body. It was discovered that the drug remains stable without decomposition even when the drug is used.

本発明はかかる新知見に基づいて完成されたものであり
、ゴム系粘着性物質よりなる膏体に、柳紫楊梅皮を配合
してなる粘着性貼付製剤用・身体、当該骨休にさらに薬
物を配合してなる粘着性貼付製剤に関する。
The present invention has been completed based on such new knowledge, and includes a adhesive patch preparation for the body, which is made of a paste made of a rubber-based adhesive substance and a paste containing willow ziyang plum peel, and a drug for the body. This invention relates to an adhesive patch preparation containing the following.

ゴム系粘着性物質としては、ゴム系粘着性貼付製剤用の
骨休として従来から使用されているジエン系高分子化合
物、具体的には天然ゴム、合成ゴム、これらの混合物な
どがあげられる。合成ゴムトンては、スチレン−イソプ
レン−スチレンブロック共重合体ゴム、スチレン−ブタ
ジェンゴム、ポリブテンゴム、ポリイソプレンゴム、ブ
チルゴム、シリコーンゴムなどがあげられる。
Examples of rubber-based adhesive substances include diene-based polymer compounds that have been conventionally used as adhesives for rubber-based adhesive patch preparations, specifically natural rubber, synthetic rubber, and mixtures thereof. Examples of synthetic rubber include styrene-isoprene-styrene block copolymer rubber, styrene-butadiene rubber, polybutene rubber, polyisoprene rubber, butyl rubber, and silicone rubber.

ゴム系粘着性物質よりなる膏体中には、さらに第三成分
としてテルペン系樹脂、石油系樹脂などの粘着付与剤、
流動パラフィン、動伯物曲(t2、とえは、オリーブ油
、大豆油、牛脂、トンJJf7 )、ポリブテン、低級
イソプレン、ワックスなどの接肴力・保持力調整剤、敞
化チタン、酸化!11!鉛、メタケイ酸アルミニウム、
硫酸カルシウム、リン酸カルシウムなどの充填剤、水及
び乳化剤(たとえば、ソルビタンモノオレエート、ラウ
リルスルホン敞ナトリウム)、乳化助剤(たとえば、ス
テアリン酸マグネシウム、ステアリンWアルミニウム)
などを配合してもよい。
The paste made of rubber-based sticky substance further contains tackifiers such as terpene-based resins and petroleum-based resins as third components.
Liquid paraffin, animal products (t2, toeha, olive oil, soybean oil, beef tallow, ton JJf7), polybutene, lower isoprene, wax and other adhesion/retention force regulators, titanium oxide, oxidation! 11! lead, aluminum metasilicate,
Fillers such as calcium sulfate and calcium phosphate, water and emulsifiers (e.g. sorbitan monooleate, sodium lauryl sulfone), emulsifiers (e.g. magnesium stearate, aluminum stearate)
etc. may also be blended.

本発明にて用いられる柳紫は、ヤナギ科値物の種子で、
サリシン(サリゲニンーグルコサイド)、ボブリン(ペ
ンジルーサリシン)を含有するものをいい、たとえばシ
ダレヤナギ(5alix babylo −nica 
)、ハコヤナギ(Poplus 5ieboldi M
IQ−)の柚子が好適なものとして例示される。
The willow purple used in the present invention is a seed of a species belonging to the Salicaceae family,
It refers to those containing salicin (saligenin glucoside) and boblin (pendylus salicin), such as weeping willow (5alix babylo-nica).
), cottonwood (Poplus 5ieboldi M
IQ-) yuzu is exemplified as a suitable one.

当該柳紫は、水、アルコール(メタノール、エタノール
、n−プロパツール)、ケトン(アセトン)などの伸性
の高い溶奴、あるいはこれらの混合溶媒(水−アルコー
ル等の混合溶媒)で抽出したエキス、就中乾燥エキスの
態様で用いてもよい。
The willow purple is an extract extracted with water, alcohol (methanol, ethanol, n-propanol), a highly extensible melt such as ketone (acetone), or a mixed solvent thereof (mixed solvent such as water-alcohol). In particular, it may be used in the form of a dry extract.

wk皮はヤマモモ科のヤマモモ(Myrica rub
raSIEBOLDet ZUOCARINI )の樹
皮である。
The wk skin is from Myrica rub, a member of the Proteaceae family.
It is the bark of raSIEBOLDet ZUOCARINI).

当該楊梅皮も上記と同様の溶媒にて抽出して裂したエキ
ス、就中乾燥エキスの態様で使用してもよい。
The Yang Mei Peel may also be used in the form of an extract extracted and split with the same solvent as above, particularly in the form of a dried extract.

柳紫及び楊梅皮並びにこれらのエキスは通常、その乾燥
物の粉末、就中100メツシユ以下の微粉末として本発
明に供される。それらの配合量はゴム系粘着性物質に対
して、柳紫は0.01−10重散%程度(好ましくは0
.1〜4M量%程斐)が好ましく、また@梅皮は0.0
1〜10重量%程度(好ましくは0.1〜5畢旭%y度
)が好ましい。
Willow purple, Yang plum peel and their extracts are usually provided in the present invention as a powder of their dried products, especially as a fine powder of 100 mesh or less. The compounding amount of Yanagi Purple is about 0.01-10% (preferably 0.01% by weight) based on the rubber adhesive substance.
.. 1 to 4M amount%) is preferable, and @ plum peel is 0.0
It is preferably about 1 to 10% by weight (preferably 0.1 to 5% by weight).

また、これらのエキス態様における配合量は、ゴム系粘
着性物質に対して、柳紫エキス及び楊梅皮エキスとも、
それぞれ0.001〜20mW%f’l iX(好まし
くは0.01〜2里量%程pL>が好個である。
In addition, the blending amounts in these extract forms are as follows:
A preferable value is 0.001 to 20 mW% f'l iX (preferably 0.01 to 2 mW% pL), respectively.

本発明の膏体は、外皮に適用しうる薬物を配合すること
+<よって粘材性貼付製*1.lに製剤化することがで
きる。而して、本発明に係るSl・体を使用した粘着性
貼付製剤は、そこに配合された薬物が分解されることな
く安定に保たれるという効果を自する。
The paste of the present invention is made of a sticky adhesive by incorporating a drug that can be applied to the outer skin.*1. It can be formulated into 1. Thus, the adhesive patch preparation using Sl/body according to the present invention has the effect that the drug compounded therein is kept stable without being decomposed.

本発明の骨休に配合される薬物は粘着性貼付製剤化して
投与されうる条物であれば特に制限はなく、たとえば経
皮吸収性薬物(ただし、経皮吸収助剤などの助けによっ
て経皮吸収されるものであってもよく、また局所性条物
、全a性業物のいずれでもよい)、皮周疾患治原用檗物
、皮j内刺檄性薬物、不定恋訴治療用薬物などがあげら
れる。
There are no particular restrictions on the drug that can be incorporated into the medicine of the present invention as long as it can be administered in the form of an adhesive patch. It may be something that can be absorbed, and it may be either a topical or whole-body product), a medicine for treating peridermal diseases, an intradermal stinging drug, a drug for treating unrequited love complaints. etc. can be mentioned.

特に、フェノール性水酸基含有化合物、アミン糸化合物
などは、従来゛のゴム系粘着性物質よりなる背体中にお
ける含量低下が著しいので、本発明骨体はかかる薬物を
製剤化する場合に特にその意犠かある。フェノール往水
酔基含有化合物としては、たとえばサリチル酸誘導体(
サリチル故モノグリコール、サリチル酸メチルなど)、
ビタミンE及びその誘導体、カブサイシンなとかあげら
れ、またアミン系化合9り1としてはジフェンヒドラミ
ンなどのエタノールアミン系抗ヒスタミン業物、クロル
フェニラミンなどのエチレンジアミン系抗ヒスタミン薬
物、リドカインなどかあげられる。その他の某効成分と
しては、たとえばe−メントール、dt−カンファー、
チモール、d−ボルネオール4(どの苦冷性皮1t# 
i++ aN性薬物、インドメタシン、シクロフェナッ
クナトリウムなどの非ステロイド糸抗炎症薬物、デキサ
メタシン、ベタメタシンなどのステロイド糸抗炎nH剤
、クロルヘキシジンジグリコネート、アクリノール専の
殺1湘剤、トウカラシエキス、ノニルl々バニリルアミ
ド、カブサイシン、ショウキョウエキス、カンタリスチ
ンキ、カンタリジンなどの温(嶽性反胸刺戯性栗物、シ
コン、トウキなどの生薬類などがあげられる。
In particular, the content of phenolic hydroxyl group-containing compounds, amine thread compounds, etc. in the back body made of conventional rubber-based adhesive substances is significantly reduced, so the present invention is particularly useful when formulating such drugs. It's a sacrifice. Examples of compounds containing phenolic intoxicants include salicylic acid derivatives (
salicyl late monoglycol, methyl salicylate, etc.),
Examples of the amine compounds include ethanolamine antihistamines such as diphenhydramine, ethylenediamine antihistamines such as chlorpheniramine, and lidocaine. Other active ingredients include e-menthol, dt-camphor,
Thymol, d-borneol 4 (1 ton of bitter skin)
i++ aN drugs, non-steroidal anti-inflammatory drugs such as indomethacin and cyclofenac sodium, steroidal anti-inflammatory NH agents such as dexamethacin and betamethacin, chlorhexidine diglyconate, acrinol-specific anti-inflammatory agent, pepper extract, nonyl Vanillylamide, turnip saicin, ginger extract, cantharis tincture, cantharidin, and other hot herbs (herbal medicines such as chestnuts, Chinese radish, and Chinese angelica).

なお、本発明粘着性貼付製剤を調製するにあたつては結
石性物質に、まず業物を添加した後に偵察または(社)
柿皮を添加してもよいことはいうまでもない。
In preparing the adhesive patch preparation of the present invention, the commercial substance is first added to the stone-causing substance, and then a reconnaissance or
It goes without saying that persimmon peel may be added.

また、本発明粘着性貼付製剤は、皿′酵、荀、プラスチ
ックフィルム等の支持体に展延して用いられる。
Further, the adhesive patch preparation of the present invention can be used by being spread on a support such as a plate, a stick, or a plastic film.

以下に実施例及び実験例を示して本発明をより具体的に
説明するが、本発明はこれらに限定されるものではない
EXAMPLES The present invention will be explained in more detail by showing Examples and Experimental Examples below, but the present invention is not limited thereto.

なお、以下の記載において「部」とあるは「止量部」を
意味する。
In addition, in the following description, "part" means "stopping part".

実施例1 スチレン−ブタジェン−スチレンゴム43部と天然ロジ
ン25部を、150°Cに保持されたニーダ−で20分
間株り、これに偵察粉末(100メツシユ以下)2部及
び偵察エタノールエキス1部とを加えて混合し、10分
同屁林すする。次にボリブデン5部、流動ノ゛〈ラフイ
ン7部、酸化チタン粉末6部、タルク5部を添加し、1
0分聞混株して粘着性貼付製剤用膏体を得る。
Example 1 43 parts of styrene-butadiene-styrene rubber and 25 parts of natural rosin were mixed in a kneader kept at 150°C for 20 minutes, and 2 parts of scout powder (less than 100 mesh) and 1 part of scout ethanol extract were added. Add and mix and sip for 10 minutes. Next, 5 parts of bolybdenum, 7 parts of fluid rough-in, 6 parts of titanium oxide powder, and 5 parts of talc were added, and 1
Mix for 0 minutes to obtain a paste for adhesive patch preparation.

実施例2 実施例1で得られた骨休に、さらにサリチル飽゛モノグ
リコール5部、ノニル陳バニリルアミド0゜02部、ジ
フェンヒドラミン08部を加え5分間Mmすすることに
よって得たものを布の上に0.2朋の厚みに展延して結
石性貼付製剤を得る。
Example 2 5 parts of salicyl saturated monoglycol, 0.02 parts of nonylvanillylamide, and 0.8 parts of diphenhydramine were added to the bone extract obtained in Example 1, and the mixture was soaked for 5 minutes. The mixture is spread to a thickness of 0.2 mm to obtain a stone preparation.

実施例3 実/?m(夕1j 1の処方中から偵察エキスをドいた
ものを用いて実h1(Σ例1及び2に卆する手段にて粘
着性結句製剤をイυる。
Example 3 Fruit/? Using the reconnaissance extract from the formulation in Example 1 and 1, prepare an adhesive preparation using the method described in Examples 1 and 2.

実施例4 実施例1の処方において、偵察粉末の代りに、19Ji
iJ皮粉末を、偵察エタノールエキスの代りに吻1・I
ヒ皮アセトンエキスを用いたものを用いて実施例1及び
2に準する手段にて粘着性貼付製沖]を得る。
Example 4 In the formulation of Example 1, instead of scout powder, 19Ji
Use iJ skin powder instead of scout ethanol extract.
Adhesive adhesive tape [Oki] was obtained by the same method as in Examples 1 and 2 using the acetone extract of balm skin.

実施例5 実hIu例4の処方中から椙侮反アセトンエキスを除い
たものを用いて実施例1及び2に卆する手段にて粘イ1
性貼付装畑を伶る。
Example 5 Using the formulation of Actual hIu Example 4 except for the acetone extract, a viscous 1.
The sex paste field is broken.

比較例1 実施例1の処方から柳紫粉末及び少j紫エタノールエキ
スを除き、実Ia例1及び2に羊する手段にて枯右性貼
d裂創を得る。
Comparative Example 1 An atrophic patch wound was obtained by the same method as in Examples 1 and 2 except that the willow purple powder and the citrus ethanol extract were removed from the formulation of Example 1.

実施例 実施例2,3及び比較例1で得た製剤をアルミニウムー
ポリエステルラミネート包装何にて遮光1、密封包装し
て40°Cにて3ケ月向保存した場合の桑lIソの分解
率(%)を調べ、その結果を第1表に示した。
Example The decomposition rate of Mulberry Iso when the preparations obtained in Examples 2 and 3 and Comparative Example 1 were packaged in aluminum-polyester laminate packaging with light shielding and hermetically sealed at 40°C for 3 months. %) and the results are shown in Table 1.

第1表 業物の分解率(抜)Table 1: Decomposition rate of industrial products (excluded)

Claims (1)

【特許請求の範囲】[Claims] コム糸粘右性物質よりなる骨休に、4I、llI察及び
楊梅皮より選ばれる少なくとも一紳を配合してなる粘着
性貼付製剤用材体。
1. A material for an adhesive patch preparation, which is formed by blending at least one substance selected from 4I, llI and Yangmeipi into a comb-thickening substance.
JP58008132A 1983-01-20 1983-01-20 Tacky plaster base Pending JPS59134718A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP58008132A JPS59134718A (en) 1983-01-20 1983-01-20 Tacky plaster base

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP58008132A JPS59134718A (en) 1983-01-20 1983-01-20 Tacky plaster base

Publications (1)

Publication Number Publication Date
JPS59134718A true JPS59134718A (en) 1984-08-02

Family

ID=11684758

Family Applications (1)

Application Number Title Priority Date Filing Date
JP58008132A Pending JPS59134718A (en) 1983-01-20 1983-01-20 Tacky plaster base

Country Status (1)

Country Link
JP (1) JPS59134718A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101475367B1 (en) * 2012-10-19 2014-12-22 니치콘 가부시키가이샤 Solid electrolytic capacitor

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101475367B1 (en) * 2012-10-19 2014-12-22 니치콘 가부시키가이샤 Solid electrolytic capacitor

Similar Documents

Publication Publication Date Title
JPS6158446B2 (en)
JPS59134718A (en) Tacky plaster base
JPS6256129B2 (en)
JPS59181211A (en) Rubber based plaster composition
JPS59184119A (en) Rubber-based adhesive plaster
JPS6053150A (en) Rubbery sticky bandage
JPS6051109A (en) Rubber pressure-sensitive adhesive plaster
JPS5955827A (en) Plaster for adhesive salve preparation
RU2166933C1 (en) Sweat and feet hygienic deodorant, preparative form of hygienic deodorant and method of its preparation
JPS6056687B2 (en) Glue for adhesive patch preparations
JPH11180887A (en) Anti-inflammatory analgesic patch
JPS5936611A (en) Adhesive application pharmaceutical
JPS59134714A (en) Tacky plaster base
JPS59134717A (en) Tacky plaster base
JPS6051108A (en) Rubber pressure-sensitive adhesive plaster
JPS59134716A (en) Tacky plaster base
JPS5936609A (en) Adhesive application pharmaceutical
JPS6051114A (en) Remedy and preventive for contact dermatitis
JPS59193817A (en) Pharmaceutical preparation for external use
JPS5959612A (en) Plaster for adhesive salve preparation
JPS59128325A (en) Plaster for adhesive pharmaceutical
JPS5955823A (en) Plaster for adhesive salve preparation
JPS62230719A (en) Plaster containing herb crude drug
JPS5953413A (en) Plaster for adhesive salve preparation
JPS59134713A (en) Tacky base for plaster